1. Home
  2. Stocks
  3. Lalpathlab Share Price
  • Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Dr. Lal Pathlabs Share Price

    Large Cap
    ₹3,276.95
    + 2.15 (0.07%)
    • Advice
    • Hold
    20 September, 2024 10:25 BSE: 539524 NSE: LALPATHLAB ISIN: INE600L01024

    Start SIP in Dr. Lal Pathlabs

    Start SIP

    Dr. Lal Pathlabs Performance

    Day Range

    • Low 3,266
    • High 3,316
    ₹ 3,276

    52 Week Range

    • Low 1,944
    • High 3,459
    ₹ 3,276
    • Open Price3,305
    • Previous Close3,275
    • Volume34109

    Dr. Lal Pathlabs Chart

    • Over 1 Month -0.45%
    • Over 3 Month + 23.03%
    • Over 6 Month + 63.9%
    • Over 1 Year + 39.57%

    Dr. Lal Pathlabs Key Statistics

    P/E Ratio 71.8
    PEG Ratio 1.6
    Market Cap Cr
    Price to Book Ratio 14.5
    EPS 46
    Dividend 0.7
    Relative Strength Index 46.24
    Money Flow Index 49.42
    MACD Signal 50.56
    Average True Range 68.46

    Dr. Lal Pathlabs F&O

    Dr. Lal Pathlabs Futures Dr. Lal Pathlabs Option Chain

    Dr. Lal Pathlabs Investment Rating

    • Master Rating:

    • Dr Lal Pathlabs has an operating revenue of Rs. 2,287.50 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 23% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 21% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Dr. Lal Pathlabs Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 535479476532480431
    Operating Expenses Qtr Cr 379349346369344315
    Operating Profit Qtr Cr 156130130163136116
    Depreciation Qtr Cr 182019191821
    Interest Qtr Cr 667778
    Tax Qtr Cr 383131383227
    Net Profit Qtr Cr 12390881139471
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,0271,816
    Operating Expenses Annual Cr 1,4081,308
    Operating Profit Annual in Cr 559461
    Depreciation Cr 7782
    Interest Annual Cr 2734
    Tax Annual Cr 13298
    Net Profit Annual Cr 384292
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 478428
    Cash from Investing Activity Annual Cr 32-288
    Cash from Financing Annual Activity Cr -404-270
    Net Cash Flow Annual Cr 106-131
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,9001,690
    Fixed Assets Annual Cr 348366
    Total Non Current Assets Annual Cr 1,4951,510
    Total Current Assets Annual Cr 921810
    Total Assets Annual Cr 2,4152,320
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 228203
    ROE Annual % 2017
    ROCE Annual % 2723
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3129
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 602545539601541491
    Operating Expenses Qtr Cr 432401398424395375
    Operating Profit Qtr Cr 170145141178146116
    Depreciation Qtr Cr 353736363538
    Interest Qtr Cr 677889
    Tax Qtr Cr 423434423426
    Net Profit Qtr Cr 10685811098357
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2,2962,059
    Operating Expenses Annual Cr 1,6171,527
    Operating Profit Annual in Cr 609490
    Depreciation Cr 144150
    Interest Annual Cr 2938
    Tax Annual Cr 143103
    Net Profit Annual Cr 358239
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 535456
    Cash from Investing Activity Annual Cr -24-287
    Cash from Financing Annual Activity Cr -414-283
    Net Cash Flow Annual Cr 97-114
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,8491,666
    Fixed Assets Annual Cr 685762
    Total Non Current Assets Annual Cr 1,3291,412
    Total Current Assets Annual Cr 1,127973
    Total Assets Annual Cr 2,4562,386
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 226204
    ROE Annual % 1914
    ROCE Annual % 2720
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3026
    Invest in Dr. Lal Pathlabs

    Dr. Lal Pathlabs Technicals

    EMA & SMA

    Current Price
    ₹3,276.95
    + 2.15 (0.07%)
    pointer
    • Bullish Moving Average
    • ___
    • 7
    • Bearish Moving Average
    • ___
    • 9
    • 20 Day
    • ₹3,324.52
    • 50 Day
    • ₹3,200.81
    • 100 Day
    • ₹2,997.95
    • 200 Day
    • ₹2,774.15
    • 20 Day
    • ₹3,357.32
    • 50 Day
    • ₹3,218.56
    • 100 Day
    • ₹2,925.01
    • 200 Day
    • ₹2,663.91

    Dr. Lal Pathlabs Resistance and Support

    PIVOT
    ₹3,270.25
    Resistance
    First Resistance 3,300.50
    Second Resistance 3,326.20
    Third Resistance 3,356.45
    RSI 46.24
    MFI 49.42
    MACD Single Line 50.56
    MACD 22.91
    Support
    First Support 3,244.55
    Second Support 3,214.30
    Third Supoort 3,188.60

    Dr. Lal Pathlabs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 106,096 4,763,710 44.9
    Week 151,211 9,134,644 60.41
    1 Month 191,818 10,479,012 54.63
    6 Month 289,492 13,386,132 46.24

    Dr. Lal Pathlabs Result Highlights

    Dr. Lal Pathlabs Synopsis

    NSE-Medical-Services

    Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1966.80 Cr. and Equity Capital is Rs. 83.50 Cr. for the Year ended 31/03/2024. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
    Market Cap 27,369
    Sales 2,021
    Shares in Float 3.76
    No of funds 317
    Yield 0.73
    Book Value 14.39
    U/D Vol ratio 1.6
    LTDebt / Equity 5
    Alpha 0.05
    Beta 0.71

    Dr. Lal Pathlabs Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 54.6%54.6%54.6%54.61%
    Mutual Funds 9.3%6.79%5.88%5.36%
    Insurance Companies 2.84%2.3%2.73%2.61%
    Foreign Portfolio Investors 25.43%26.15%25.36%24.35%
    Financial Institutions/ Banks
    Individual Investors 4.91%6.47%7.26%8.37%
    Others 2.92%3.69%4.17%4.7%

    Dr. Lal Pathlabs Management

    Name Designation
    Brig.(Hony) Dr. Arvind Lal Executive Chairman
    Dr. Om Prakash Manchanda Managing Director
    Dr. Vandana Lal Whole Time Director
    Mr. Rahul Sharma Non Executive Director
    Dr. Archana Lal Erdmann Non Executive Director
    Mr. Gurinder Singh Kalra Independent Director
    Mr. Rajit Mehta Independent Director
    Mrs. Somya Satsangi Independent Director
    Mr. Rohit Bhasin Independent Director
    Mr. Arun Duggal Independent Director

    Dr. Lal Pathlabs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Dr. Lal Pathlabs Corporate Action

    Date Purpose Remarks
    2024-08-07 Quarterly Results & Interim Dividend
    2024-05-10 Audited Results & Final Dividend
    2024-02-01 Quarterly Results & Interim Dividend
    2023-11-02 Quarterly Results
    2023-07-27 Quarterly Results & Interim Dividend
    Date Purpose Remarks
    2024-08-20 INTERIM Rs.6.00 per share(60%)Interim Dividend
    2024-06-10 FINAL Rs.6.00 per share(60%)Final Dividend
    2024-02-13 INTERIM Rs.12.00 per share(120%)Interim Dividend
    2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend
    2023-08-11 INTERIM Rs.6.00 per share(60%)Interim Dividend

    Dr. Lal Pathlabs MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 95,391
    HDFC Flexi Cap Fund Growth 63,436
    Kotak Equity Arbitrage Fund Growth 53,423
    SBI Arbitrage Opportunities Fund Regular Growth 32,415
    SBI Large & Midcap Fund Regular Payout Inc Dist cum Cap Wdrl 28,172

    Dr. Lal Pathlabs FAQs

    What is Share Price of Dr. Lal Pathlabs ?

    Dr. Lal Pathlabs share price is ₹3,276 As on 20 September, 2024 | 10:11

    What is the Market Cap of Dr. Lal Pathlabs ?

    The Market Cap of Dr. Lal Pathlabs is ₹27386.9 Cr As on 20 September, 2024 | 10:11

    What is the P/E ratio of Dr. Lal Pathlabs ?

    The P/E ratio of Dr. Lal Pathlabs is 71.8 As on 20 September, 2024 | 10:11

    What is the PB ratio of Dr. Lal Pathlabs ?

    The PB ratio of Dr. Lal Pathlabs is 14.5 As on 20 September, 2024 | 10:11

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.